Potential Epigenetic Biomarkers for Prostate Cancer Screening

Potential Epigenetic Biomarkers for Prostate Cancer Screening

Bibliographic Details
Main Author:	Jong-Myon Bae
Format:	Article
Language:	English
Published:	Korean Continence Society 2018-06-01
Series:	International Neurourology Journal
Online Access:	http://www.einj.org/upload/pdf/inj-1836096-048.pdf

Similar Items

Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers
by: Guzel Rafikova, et al.
Published: (2023-08-01)

Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential
by: Marianne Trier Bjerre, et al.
Published: (2020-05-01)

Unveiling the potential of SLURP1 protein as a biomarker for prostate cancer screening
by: Tianyin Yang, et al.
Published: (2024-04-01)

Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality
by: Ruth Pidsley, et al.
Published: (2022-10-01)

Editorial: Epigenetics in prostate cancer
by: Aria Baniahmad, et al.
Published: (2023-11-01)

Epigenetic regulation of prostate cancer
by: Ruixin Wang, et al.
Published: (2020-12-01)

Cancer Epigenetic Biomarkers
by: Fabio Coppedè
Published: (2023-11-01)

Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis
by: Priyadarshana Ajithkumar, et al.
Published: (2024-01-01)

Modifiable risk factors of lung cancer in “never-smoker” women
by: Jong-Myon Bae
Published: (2015-10-01)

Primary Care Physicians’ Action Plans for Responding to Results of Screening Tests Based on the Concept of Quaternary Prevention
by: Jong-Myon Bae, et al.
Published: (2016-11-01)

Epigenetic and Epitranscriptomic Control in Prostate Cancer
by: Judith López, et al.
Published: (2022-02-01)

Prostate cancer screening: Continued controversies and novel biomarker advancements
by: Atiyah Tidd-Johnson, et al.
Published: (2022-12-01)

Liquid Biopsy Potential Biomarkers in Prostate Cancer
by: Jochen Neuhaus, et al.
Published: (2018-09-01)

Statin Intake and Gastric Cancer Risk: An Updated Subgroup Meta-analysis Considering Immortal Time Bias
by: Jong-Myon Bae
Published: (2022-09-01)

Screening for Colorectal Cancer Leading into a New Decade: The “Roaring ‘20s” for Epigenetic Biomarkers?
by: Hélder Almeida-Lousada, et al.
Published: (2021-11-01)

Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study
by: Adams, Charleen D., et al.
Published: (2018)

Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment
by: Shouyi Zhang, et al.
Published: (2023-04-01)

Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention
by: Simona Izzo, et al.
Published: (2020-04-01)

Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer
by: Juan C. Pardo, et al.
Published: (2022-02-01)

Epigenetic Editing in Prostate Cancer: Challenges and Opportunities
by: Mariana Brütt Pacheco, et al.
Published: (2022-05-01)

Epigenetic Therapies and Biomarkers in Breast Cancer
by: Lauren Julia Brown, et al.
Published: (2022-01-01)

MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer
by: Valentina Doldi, et al.
Published: (2021-05-01)

Clinical Applications of Liquid Biopsy in Prostate Cancer: From Screening to Predictive Biomarker
by: Filip Ionescu, et al.
Published: (2022-03-01)

Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening
by: Joel Andersson, et al.
Published: (2022-10-01)

The epigenetic function of androgen receptor in prostate cancer progression
by: Takahiro Sawada, et al.
Published: (2023-03-01)

The Interactions of microRNA and Epigenetic Modifications in Prostate Cancer
by: Prashant Kumar Singh, et al.
Published: (2013-08-01)

Are elevated mitochondrial DNA fragments in prostatic inflammation a potential biomarker for prostate cancer?
by: Ugur Aferin, et al.
Published: (2023-09-01)

Screening for prostate cancer.
by: Carlsson, S, et al.
Published: (2012)

Prostate cancer screening
by: James Eastham
Published: (2017-07-01)

Research progress and applications of epigenetic biomarkers in cancer
by: Jianjun Gao, et al.
Published: (2024-04-01)

Epigenetic modifications in esophageal cancer: An evolving biomarker
by: Wen-Jian Liu, et al.
Published: (2023-01-01)

Searching for cancer biomarkers in the human epigenetic landscape
by: Jackson, F
Published: (2024)

Quantitative Analysis of Seven New Prostate Cancer Biomarkers and the Potential Future of the ‘Biomarker Laboratory’
by: Kevin Cao, et al.
Published: (2018-07-01)

Leucine zipper protein 2 serves as a prognostic biomarker for prostate cancer correlating with immune infiltration and epigenetic regulation
by: Dechao Feng, et al.
Published: (2022-10-01)

On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.
by: Bangma, C, et al.
Published: (2010)

Lectins: an effective tool for screening of potential cancer biomarkers
by: Onn Haji Hashim, et al.
Published: (2017-09-01)

Lectins: an effective tool for screening of potential cancer biomarkers
by: Hashim, Onn Haji, et al.
Published: (2017)

Exploiting epigenetic targets to overcome taxane resistance in prostate cancer
by: Buse Cevatemre, et al.
Published: (2024-02-01)

Alterations in the Epigenetic Machinery Associated with Prostate Cancer Health Disparities
by: Jenna Craddock, et al.
Published: (2023-07-01)

CHD1, a multifaceted epigenetic remodeler in prostate cancer
by: Haoyan Li, et al.
Published: (2023-01-01)